Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Zhejiang University. Medical sciences ; (6): 296-302, 2019.
Artigo em Chinês | WPRIM | ID: wpr-775220

RESUMO

OBJECTIVE@#To investigate the effects of high dose vitamin C (VC) on proliferation of breast cancer cells and to explore its mechanisms.@*METHODS@#Human breast cancer cells Bcap37 and MDA-MB-453 were treated with VC at low dose (0.01 mmol/L), medium dose (0.10 mmol/L) and high dose (2.00 mmol/L). Cell proliferation was determined with CCK-8 assay, protein expression was evaluated by Western blot, and the secretion of lactic acid in tumor cells was detected by colorimetric method. Bcap37 cells were inoculated in nude mice, and tumor baring nude mice were intraperitoneally injected with high VC(4 g/kg, VC group, =5)or normal saline (control group, =5) for 24 d. Tumor weight and body weight were calculated.@*RESULTS@# experiments demonstrated that high dose VC significantly inhibited cell proliferation in Bcap37 and MDA-MB-453 cells (all <0.01); the expressions of Glut1 and mTOR signaling pathway-related proteins were decreased (all <0.05); and the secretion of lactic acid was also markedly reduced (all <0.05). experiment showed that the tumor weight was decreased in mice treated with high-dose VC as compared with control group (<0.05), but no difference in body weights between two groups was observed.@*CONCLUSIONS@#High dose VC may inhibit proliferation of breast cancer cells both and through reducing glycolysis and protein synthesis.


Assuntos
Animais , Humanos , Camundongos , Ácido Ascórbico , Farmacologia , Neoplasias da Mama , Tratamento Farmacológico , Linhagem Celular Tumoral , Proliferação de Células , Glicólise , Camundongos Nus , Biossíntese de Proteínas
2.
Journal of Zhejiang University. Medical sciences ; (6): 443-449, 2018.
Artigo em Chinês | WPRIM | ID: wpr-775295

RESUMO

OBJECTIVE@#To investigate whether rapamycin treatment starting at 24 h after cerebral ischemia/reperfusion(I/R) has protective effect on brain injury in rats.@*METHODS@#The rat I/R model was established by middle cerebral artery occlusion according to Longa's method. A total of 104 Sprague Dawley rats were randomly divided into sham group, model group, and rapamycin-treated groups (6 h or 24 h after modeling). Neurological function was assessed with neurological severity score (NSS). Triphenyl tetrazolium chloride (TTC) staining and Fluoro-Jade B (FJB) staining were used to examine the infarct volume and neuronal apoptosis, respectively. The expression of p-S6 protein in mTOR signaling pathway was detected by Western blot analysis.@*RESULTS@#Compared with sham group, NSS of the model group was significantly increased and TTC staining indicated obvious infarct area (all 0.05).@*CONCLUSIONS@#Rapamycin treatment starting at 24 h after I/R exhibits protective effect on brain injury in rats.


Assuntos
Animais , Ratos , Isquemia Encefálica , Tratamento Farmacológico , Imunossupressores , Usos Terapêuticos , Infarto da Artéria Cerebral Média , Tratamento Farmacológico , Distribuição Aleatória , Ratos Sprague-Dawley , Traumatismo por Reperfusão , Sirolimo , Usos Terapêuticos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA